Text Size
S
M
L
Listen
Santen Global
menu
Patients
Healthcare Professionals
Careers
Investors
Listen
Tap on the left to use.
Who We Are
Message
Message from the CEO
Corporate Story
Corporate Story
CORE PRINCIPLE / Our Commitment
CORE PRINCIPLE / Our Commitment
Our Values
Our Values
History
History of Santen
Corporate Executives
Corporate Executives
Corporate Governance
Corporate Governance
Policies
Policies and Statements
Company Infomation
Overview / Map
Global Operation
What We Do
MTP & Santen 2030
Medium-term Management Plan
Santen 2030
Efforts to Enhance Patients' Satisfaction
Efforts to Enhance Product Safety
Efforts to Enhance Product Usability
Efforts to Address Untreated Patients
Research & Development
Research & Development
The Ophthalmic Product Process: R&D
Clinical Trial Information
Partnering
Santen's Partnership
Our Partners
Partnering Contact
Production
Production
Safety and Quality Assurance
The Ophthalmic Production Process: Production
Sales & Marketing
Sales & Marketing
Our Stories
Sustainability
Sustainability
Our Sustainability Commitment
Sustainability at Santen
Social
Access to Healthcare
Research & Development in Ophthalmology
Product Quality & Safety
Supply Chain
Human Rights
Talent
Digital Transformation (DX)
Governance
Corporate Governance
Compliance
Ethical Marketing
Risk Management
Information Security
Environment
Environmental initiatives
Measures against Climate Change
Environmental Load Reduction
Biodiversity
Disclosures Based on the TCFD Recommendations
Inclusion
Inclusive Society Santen Promotes
Inclusion Starting from Blind Football
Together with Society
With Employees
Related Information
Participating in the UN Global Compact
Social Contribution Activities
Stakeholder Engagement
Environment Data (up-to-date)
Social Data (up-to-date)
Governance Data (up-to-date)
GRI Standards Content Index
Sustainability Library
External Assessment
News
News
Show All
Press Release
IR News
Information
HOME
Investors
IR Library
Presentation Materials·Videos
Investor Meeting Full Year Results; year ended Mar 31, 2007
Investor Meeting Full Year Results; year ended Mar 31, 2007
Takakazu Morita
Chairman and CEO
Summary of the Year Ended March 2007
Forecast of the Year Ending March 2008
Status of 2006-2010 Medium-term Management Plan
Takeover Defense Measures and Policy for Return to Shareholders (PDF: 85KB)
PDF file.
Page will open in a new window.
Akira Kurokawa
President and COO
Key Measures to be Implemented in FY2007 (PDF: 26KB)
PDF file.
Page will open in a new window.
Yoshihiro Noutsuka
Corporate Officer
Head of Planning and Control Division
Consolidated Financial Results for the Year ended March 31, 2007
Consolidated Financial Forecasts for the Year ending March, 2008 (PDF: 269KB)
PDF file.
Page will open in a new window.
Toshiaki Nishihata, Ph.D.
Senior Corporate Officer
Head of Research and Development Division
Status of Clinical Development (PDF: 31KB)
PDF file.
Page will open in a new window.